Floatz logo

Xirestomig

Mature B-cell Non-Hodgkin Lymphoma

Antengene (Hangzhou) Biologics Co., Ltd.monoclonal_antibodyPhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
89/ 100

Competitive context

316 Active assets in the Mature B-cell Non-Hodgkin Lymphoma cohort.

Asset / SponsorPhaseRating
VINDESINE
Children's Cancer Group, China
Phase 4BBB
Odronextamab
University of Birmingham
Phase 3BBB
cc-5013
Shanghai Junshi Bioscience Co., Ltd.
Phase 4BBB
Cytosin-Arabinosid
Children's Cancer Group, China
Phase 4BBB
METHOTREXATE
Children's Cancer Group, China
Phase 4BBB

View all 50 →

Same molecule, other indications

Xirestomig is also rated in:

Metastatic Solid TumorDormant
C
Indicative ·
37 / 100
View asset →
cancerDormant
C
Indicative ·
36 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →